November 24, 2015
Eli Lilly and Company has filed a lawsuit in Tokyo seeking to block Japanese generic major Sawai Pharmaceutical from rolling out a generic version of Evista (raloxifene) - a new twist in the two companies’ patent disputes over the mainstay...read more